55.81
1.15%
-0.65
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $55.81, with a volume of 10.28M.
It is down -1.15% in the last 24 hours and down -9.31% over the past month.
See More
Previous Close:
$56.46
Open:
$56.74
24h Volume:
10.28M
Relative Volume:
1.07
Market Cap:
$72.42B
Revenue:
$363.25B
Net Income/Loss:
$7.19B
P/E Ratio:
8.4178
EPS:
6.63
Net Cash Flow:
$5.27B
1W Performance:
-1.20%
1M Performance:
-9.31%
6M Performance:
-0.89%
1Y Performance:
-18.80%
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
May-30-24 | Initiated | Robert W. Baird | Neutral |
May-07-24 | Downgrade | TD Cowen | Buy → Hold |
May-02-24 | Downgrade | UBS | Buy → Neutral |
May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
Mar-06-24 | Initiated | Barclays | Equal Weight |
Feb-26-24 | Initiated | Leerink Partners | Outperform |
Dec-22-23 | Initiated | HSBC Securities | Buy |
Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
May-26-23 | Initiated | Piper Sandler | Overweight |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
Nov-23-22 | Resumed | Morgan Stanley | Overweight |
Jun-17-22 | Initiated | Loop Capital | Buy |
May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
Dec-14-21 | Initiated | Goldman | Buy |
Dec-01-21 | Initiated | Seaport Research Partners | Buy |
May-19-21 | Initiated | Wells Fargo | Equal Weight |
Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
Sep-17-20 | Initiated | Piper Sandler | Overweight |
Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
Sep-12-19 | Initiated | Deutsche Bank | Buy |
Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
Apr-18-19 | Initiated | Guggenheim | Buy |
Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
Apr-10-19 | Reiterated | BofA/Merrill | Buy |
Mar-13-19 | Initiated | Bernstein | Outperform |
Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
Jan-17-19 | Initiated | UBS | Buy |
Dec-18-18 | Initiated | Barclays | Overweight |
Nov-29-18 | Resumed | Goldman | Neutral |
Nov-28-18 | Initiated | Evercore ISI | Outperform |
Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
Feb-27-18 | Resumed | BofA/Merrill | Buy |
Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
US Bancorp DE Cuts Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS faces credit rating review as debt leverage climbs - The Business Journals
CVS Health Stock: Analyst Estimates & Ratings - Barchart
Willow Grove man charged with insider trading after making $617K on CVS Health deal - Glenside Local
Curious about CVS Health (CVS) Q3 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance
Willow Grove man faces insider trading charges after CVS-Oak Street deal - The Philadelphia Inquirer
CVS Unit Exec's Ex-Partner Charged With Insider Trading - Law360
Scientist Charged With Trading on Domestic Partner’s Deal Secret - Bloomberg
SEC Sues Scientist for Insider Trading in CVS-Oak Street Merger - Bloomberg Law
Pennsylvania man charged with insider trading related to CVS takeover - MSN
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
Pennsylvania man charged with insider trading related to CVS takeover By Reuters - Investing.com
CVS Credit Rating at Risk After Growth Gamble Fails to Pay Off - Bloomberg
CVS Health Corporation (CVS): Among The 10 Oversold Blue Chip Stocks to Buy Now - Insider Monkey
CVS Health Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
10 Oversold Blue Chip Stocks to Buy Now - Insider Monkey
Earnings Preview: CVS Health (CVS) Q3 Earnings Expected to Decline - Yahoo Finance
CVS Health Insider Lowered Holding By 40% During Last Year - Yahoo Finance
CVS Health (CVS) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
CVS Health (CVS) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
CVS Health Corporation (CVS): Is This High Growth Retail Stock Profitable in 2024? - Insider Monkey
Mirae Asset Global Investments Co. Ltd. Sells 8,763 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Is CVS Health Corporation (CVS) the Most Profitable Value Stock To Invest In? - Insider Monkey
CVS needs ‘realistic targets’ it can exceed says analyst after CEO dismissal - Yahoo Finance
CVS appoints new CEO amid restructuring - The Ticker
DekaBank Deutsche Girozentrale Has $113.86 Million Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS CEO Exit Ends Promising Era of Women Heading Pharmacy Chains - MSN
CVS Caremark To Report Q4 Results: Earnings Preview - RTTNews
CVS Caremark Q4 Profit Slightly Down; Adj. EPS Tops ViewUpdate - RTTNews
CVS Caremark Q3 Profit Rises; Lifts FY11 EPS ViewUpdate - RTTNews
CVS Caremark Operating Chief Merlo To Become CEO In March - RTTNews
CVS Caremark Q4 Results Tops Estimates, Lifts 2013 Outlook - RTTNews
CVS names Joyner as CEO under investor pressure, withdraws profit forecast - MSN
International Assets Investment Management LLC Buys 1,133,184 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Health insurers unveil Medicare Advantage plans for 2025 - MSN
More US firms lean on retired, veteran leaders to steady ship in choppy economy - MSN
Inside CVS and Walgreens' downturn: How misguided M&A damaged America's drugstores - Fortune
CVS Health Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
How misguided M&A damaged America’s drugstores - Yahoo Finance
CVS Health Co. (NYSE:CVS) Shares Purchased by Cullinan Associates Inc. - MarketBeat
Analysis-Can the new CVS CEO handle the Aetna challenge? - MSN
CVS shows women are hired to do impossible jobs - Victoria Advocate
CVS Health Corp. stock underperforms Thursday when compared to competitors - MarketWatch
SoCal Union Workers, CVS Reach Tentative Agreement - Progressive Grocer
CVS Q3 Estimates Plunge Before Earnings Release: How to Play the Stock - Yahoo Finance
CVS Health Stock Dip: Undervalued And Ready For A Turnaround (NYSE:CVS) - Seeking Alpha
A new CVS partnership supports coordinated health care, free Uber rides to appointments - The Atlanta Journal Constitution
Mizuho cuts CVS Health stock price target, keeps Outperform rating - Investing.com
Is CVS Health (NYSE:CVS) Using Too Much Debt? - Yahoo Finance
SOL Capital Management CO Acquires 9,075 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cvs Health Corp Stock (CVS) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Mahoney Michael F | Director |
May 02 '24 |
Buy |
54.49 |
9,181 |
500,294 |
9,356 |
Shah Prem S | EVP and Pres-Pharm, Consumer W |
Feb 16 '24 |
Sale |
76.95 |
29,473 |
2,267,947 |
39,765 |
LUDWIG EDWARD J | Director |
Nov 03 '23 |
Buy |
70.47 |
2,000 |
140,930 |
20,630 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):